Literature DB >> 15678760

A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.

Takahiro Kawaji1, Yukio Ando, Eiko Ando, Masaaki Nakamura, Akira Hirata, Hidenobu Tanihara.   

Abstract

We describe a case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy (FAP) associated with Val30Met transthyretin mutation. A healthy 74-year-old woman noticed left blurred vision and floaters in 1992. Severe vitreous opacities were identified in the left eye. The patient displayed no systemic symptoms, and Congo red staining of the biopsy samples of the stomach and duodenum revealed no amyloid deposition. A diagnosis of FAP was confirmed following genetic investigation. Vitrectomy and cataract surgery was performed with intraocular lens implantation in April 1998. Histopathological examination of the vitreous material revealed amyloid fibrils. Intraocular pressure (IOP) gradually elevated and cupping of the optic disc enlarged. Trabeculectomy was performed in February 2000, but postoperative IOP was again elevated and a needling procedure was performed in March 2000. No postoperative recurrence of vitreous opacity has been reported and IOP has remained well controlled. In the present case, ocular manifestations were the only symptoms of FAP and systemic symptoms have not developed, after more than 12 years. FAP should be suspected as the cause in cases of vitreous opacities in patients from areas with endemic foci of FAP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15678760     DOI: 10.1080/13506120400015580

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  6 in total

1.  Vitrectomy for vitreous amyloidosis.

Authors:  Jiang You
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

2.  Reply to: "Bilateral Non-arteritic Anterior Ischaemic Optic Neuropathy as the Presentation of Systemic Amyloidosis".

Authors:  Francesco Pellegrini; Daniele Cirone; Luca De Simone; Luca Cimino; Cristina Ciabattoni
Journal:  Neuroophthalmology       Date:  2017-09-27

3.  Transthyretin Arg-83 mutation in vitreous amyloidosis.

Authors:  Ling-Yan Chen; Lin Lu; Yong-Hao Li; Hui Zhong; Wang Fang; Li Zhang; Weng-Lin Li
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

4.  Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.

Authors:  João Melo Beirão; Jorge Malheiro; Carolina Lemos; Idalina Beirão; Paulo Costa; Paulo Torres
Journal:  Amyloid       Date:  2015-06-22       Impact factor: 7.141

5.  Mutation p.G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families.

Authors:  A-Mei Zhang; Hui Wang; Peng Sun; Qiu-Xiang Hu; Yuqing He; Yong-Gang Yao
Journal:  Mol Vis       Date:  2013-07-25       Impact factor: 2.367

Review 6.  Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review.

Authors:  A C Martins; A M Rosa; E Costa; C Tavares; M J Quadrado; J N Murta
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.